Treatment of venereal diseases.
D002602:Chancroid / Q000188:drug therapy; D004338:Drug Combinations; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy; D006100:Granuloma Inguinale; D006801:Humans; D007273:Injections, Intramuscular; D007612:Kanamycin / Q000008:administration & dosage / Q000627:therapeutic use; D008219:Lymphogranuloma Venereum / Q000188:drug therapy; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D010403:Penicillin Resistance; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D012749:Sexually Transmitted Diseases / Q000188:drug therapy*; D013307:Streptomycin / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013587:Syphilis / Q000188:drug therapy; D013752:Tetracycline / Q000008:administration & dosage / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014526:Urethritis / Q000188:drug therapy
D004338:Drug Combinations; D010406:Penicillins; D013449:Sulfonamides; D008795:Metronidazole; D007612:Kanamycin; D004917:Erythromycin; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole; D012293:Rifampin; D013307:Streptomycin